NDC 51662-1291

DOPAMINE HCI

Dopamine Hci

DOPAMINE HCI is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Dopamine Hydrochloride.

• Product ID: 51662-1291_763d2b07-9ceb-782e-e053-2a91aa0adc01
• NDC: 51662-1291
• Product Type: Human Prescription Drug
• Proprietary Name: DOPAMINE HCI
• Generic Name: Dopamine Hci
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2018-09-19
• Marketing Category: NDA / NDA
• Application Number: NDA018132
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: DOPAMINE HYDROCHLORIDE
• Active Ingredient Strength: 40 mg/mL
• Pharm Classes: Catecholamine [EPC],Catecholamines [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51662-1291-1

10 mL in 1 VIAL, SINGLE-DOSE (51662-1291-1)

• Marketing Start Date: 2018-09-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1291-1 [51662129101]

DOPAMINE HCI INJECTION, SOLUTION, CONCENTRATE

• Marketing Category: NDA
• Application Number: NDA018132
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-09-19
• Inactivation Date: 2020-01-31
• Reactivation Date: 2020-02-07

Drug Details

Active Ingredients

Ingredient	Strength
DOPAMINE HYDROCHLORIDE	40 mg/mL

OpenFDA Data

• SPL SET ID: 763d2b07-9cea-782e-e053-2a91aa0adc01
• Manufacturer:
  • HF Acquisition Co LLC, DBA HealthFirst
• UNII:
  • 7L3E358N9L

Pharmacological Class

• Catecholamine [EPC]
• Catecholamines [CS]

NDC Crossover Matching brand name "DOPAMINE HCI" or generic name "Dopamine Hci"

NDC	Brand Name	Generic Name
51662-1220	DOPAMINE HCI	DOPAMINE HCI
51662-1291	DOPAMINE HCI	DOPAMINE HCI